Stephan Lauxmann

Hoppe Seyler Str. 3
Tuebingen, BW 72076, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Antineuronal antibody titres in autoimmune encephalitis: clinical implications for diagnosis and long-term immunotherapy.

Antineuronal antibody titres in autoimmune encephalitis: clinical implications for diagnosis and long-term immunotherapy.

Journal: Frontiers in immunology

Published: December 19, 2025

Reliable detection of focal onset impaired awareness seizures in patients with epilepsy using wearable ECG: Development and validation study.

Reliable detection of focal onset impaired awareness seizures in patients with epilepsy using wearable ECG: Development and validation study.

Journal: Computer methods and programs in biomedicine

Published: May 22, 2025

Correction to: Cenobamate: real-world data from a retrospective multicenter study.

Correction to: Cenobamate: real-world data from a retrospective multicenter study.

Journal: Journal of neurology

Published: August 21, 2024

Connectome-based disentangling of epilepsy networks from insular stereoelectroencephalographic leads.

Connectome-based disentangling of epilepsy networks from insular stereoelectroencephalographic leads.

Journal: Frontiers in neurology

Published: July 06, 2024

Cenobamate: real-world data from a retrospective multicenter study.

Cenobamate: real-world data from a retrospective multicenter study.

Journal: Journal of neurology

Published: April 25, 2024

Loss or gain of function? Effects of ion channel mutations on neuronal firing depend on the neuron type.

Loss or gain of function? Effects of ion channel mutations on neuronal firing depend on the neuron type.

Journal: Frontiers in neurology

Published: March 27, 2023

Exome sequencing of 20,979 individuals with epilepsy reveals shared and distinct ultra-rare genetic risk across disorder subtypes.

Exome sequencing of 20,979 individuals with epilepsy reveals shared and distinct ultra-rare genetic risk across disorder subtypes.

Journal: medRxiv : the preprint server for health sciences

Published: March 03, 2023

4-Aminopyridine is a promising treatment option for patients with gain-of-function KCNA2-encephalopathy.

4-Aminopyridine is a promising treatment option for patients with gain-of-function KCNA2-encephalopathy.

Journal: Science translational medicine

Published: September 13, 2021

In vitro effects of eslicarbazepine (S-licarbazepine) as a potential precision therapy on SCN8A variants causing neuropsychiatric disorders.

In vitro effects of eslicarbazepine (S-licarbazepine) as a potential precision therapy on SCN8A variants causing neuropsychiatric disorders.

Journal: British journal of pharmacology

Published: August 20, 2021

Therapeutic Potential of Sodium Channel Blockers as a Targeted Therapy Approach in KCNA1-Associated Episodic Ataxia and a Comprehensive Review of the Literature.

Therapeutic Potential of Sodium Channel Blockers as a Targeted Therapy Approach in KCNA1-Associated Episodic Ataxia and a Comprehensive Review of the Literature.

Journal: Frontiers in neurology

Published: May 01, 2021

Genetics of Paroxysmal Dyskinesia: Novel Variants Corroborate the Role of KCNA1 in Paroxysmal Dyskinesia and Highlight the Diverse Phenotypic Spectrum of KCNA1- and SLC2A1-Related Disorders.

Genetics of Paroxysmal Dyskinesia: Novel Variants Corroborate the Role of KCNA1 in Paroxysmal Dyskinesia and Highlight the Diverse Phenotypic Spectrum of KCNA1- and SLC2A1-Related Disorders.

Journal: Frontiers in neurology

Published: April 27, 2021

Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications.

Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications.

Journal: Brain : a journal of neurology

Published: March 12, 2021

Showing 1-12 of 18

Last Updated: 09/26/2026